CRISPR Therapeutics CRSP Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's common stock?
- CRISPR Therapeutics (CRSP) reported common stock of $3.12M in Q1 2026.
- How has CRISPR Therapeutics's common stock changed year-over-year?
- CRISPR Therapeutics's common stock increased by 14.5% year-over-year, from $2.72M to $3.12M.
- What is the long-term trend for CRISPR Therapeutics's common stock?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's common stock has grown at a 6.3% compound annual growth rate (CAGR), from $2.28M to $3.09M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).